Hovione 2023 CDMO Leadership Awards Winner Interview
Outsourced Pharma, April 2023
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Outsourced Pharma, April 2023
Hovione is proud to announce the opening of a state-of-the-art continuous tableting (CT) line at its R&D Center in Lisbon.
Safety First, Quality Always: We are continuously improving the safety of our operations with the patient’s safety in mind.
Its lead single-use nasal dry powder device now available for commercial partnerships
Hovione won the 2023 CDMO Leadership Award across all six categories across all three groups of respondents
Hovione is closer to its customers with a new website in Mandarin
Presented by the Hénokiens Association and the Château du Clos Lucé